Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27331 | 18636654 | World J Gastroenterol | Hepatic steatosis: a benign disease or a silent killer. | 2008 | Details |
| A27332 | 18630587 | Zhen Ci Yan Jiu | [Influence of electroacupuncture on insulin-resistance in nonalcoholic fatty liver rats]. | 2008 | Details |
| A27333 | 18627003 | Hepatology | Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. | 2008 | Details |
| A27335 | 18625429 | Clin Liver Dis | Hepatitis C infection and nonalcoholic fatty liver disease. | 2008 | Details |
| A27338 | 18617560 | J Physiol | Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. | 2008 | Details |
| A27339 | 18617457 | Orv Hetil | [Non-alcoholic fatty liver disease and cardiovascular risk]. | 2008 | Details |
| A27347 | 18608565 | Int J Food Sci Nutr | Is there any association between high-density lipoprotein, insulin resistance and non-alcoholic fatty liver disease in obese children? | 2009 | Details |
| A27351 | 18591439 | Circulation | Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. | 2008 | Details |
| A27354 | 18571268 | Diabetes Res Clin Pract | Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. | 2008 | Details |
| A27356 | 18565127 | Int J Clin Pract | The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. | 2008 | Details |
| A27358 | 18564173 | Diabetes Obes Metab | Current treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27365 | 18537181 | Hepatology | Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. | 2008 | Details |
| A27366 | 18532991 | Aliment Pharmacol Ther | Review article: diagnosis and treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27367 | 18532884 | Clin Infect Dis | Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. | 2008 | Details |
| A27369 | 18516264 | Ther Clin Risk Manag | Treatment of non-alcoholic fatty liver disease. | 2007 | Details |
| A27377 | 18510853 | Zhonghua Gan Zang Bing Za Zhi | [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease]. | 2008 | Details |
| A27378 | 18510618 | Am J Gastroenterol | Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. | 2008 | Details |
| A27381 | 18506842 | Hepatology | Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. | 2008 | Details |
| A27382 | 18505888 | J Clin Pathol | Clinical and laboratory diagnosis of the metabolic syndrome. | 2008 | Details |
| A27384 | 18501344 | Eur J Pharmacol | Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. | 2008 | Details |
| A27385 | 18501116 | Acta Pharmacol Sin | Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. | 2008 | Details |
| A27386 | 18500507 | Obes Surg | A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). | 2008 | Details |
| A27389 | 18492015 | Liver Int | Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. | 2008 | Details |
| A27392 | 18486862 | J Adolesc Health | Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. | 2008 | Details |
| A27394 | 18484615 | Anat Rec (Hoboken) | Hepatic microcirculation in fatty liver disease. | 2008 | Details |
| A27396 | 18473416 | World J Gastroenterol | Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. | 2008 | Details |
| A27398 | 18471547 | Gastroenterology | Diagnosis and therapy of nonalcoholic steatohepatitis. | 2008 | Details |
| A27401 | 18465245 | Dig Dis Sci | Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. | 2008 | Details |
| A27402 | 18462969 | Growth Horm IGF Res | Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. | 2008 | Details |
| A27411 | 18445142 | Aliment Pharmacol Ther | Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. | 2008 | Details |
| A27412 | 18442193 | World J Gastroenterol | Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. | 2008 | Details |
| A27413 | 18435716 | Liver Int | Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. | 2008 | Details |
| A27417 | 18422468 | Expert Opin Pharmacother | Pleiotropic effects of thiazolidinediones. | 2008 | Details |
| A27418 | 18421281 | Obesity (Silver Spring) | Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. | 2008 | Details |
| A27420 | 18419637 | J Dig Dis | Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. | 2008 | Details |
| A27421 | 18417155 | Life Sci | The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. | 2008 | Details |
| A27424 | 18410557 | Aliment Pharmacol Ther | Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2008 | Details |
| A27425 | 18405489 | Gastroenterol Hepatol | [Treatment of fatty liver disease]. | 2008 | Details |
| A27428 | 18336657 | J Gastroenterol Hepatol | Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. | 2008 | Details |
| A27429 | 18336651 | J Gastroenterol Hepatol | Fat paradox of steatohepatitis. | 2008 | Details |
| A27430 | 18397387 | Aliment Pharmacol Ther | Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. | 2008 | Details |
| A27431 | 18396752 | Acta Gastroenterol Belg | The metabolic syndrome and the liver. | 2008 | Details |
| A27434 | 18395287 | J Hepatol | Fructose consumption as a risk factor for non-alcoholic fatty liver disease. | 2008 | Details |
| A27435 | 18391799 | Gastroenterol Nurs | Pediatric nonalcoholic fatty liver disease. | 2008 | Details |
| A27436 | 18390575 | Gut | Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. | 2008 | Details |
| A27437 | 18388185 | Am J Physiol Gastrointest Liver Physiol | Gene expression in human NAFLD. | 2008 | Details |
| A27438 | 18386618 | Rom J Intern Med | Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease. | 2006 | Details |
| A27444 | 23105738 | Indian J Clin Biochem | Hyperinsulinemia predisposes to NAFLD. | 2008 | Details |
| A27448 | 18370830 | Metab Syndr Relat Disord | Nonalcoholic steatohepatitis and the metabolic syndrome. | 2008 | Details |
| A27449 | 18370827 | Metab Syndr Relat Disord | Is cholangiocarcinoma another complication of insulin resistance: a report of three cases. | 2007 | Details |
| A27451 | 18369681 | Obes Surg | Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. | 2008 | Details |
| A27452 | 18367860 | Korean J Hepatol | [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. | 2008 | Details |
| A27453 | 18367854 | Korean J Hepatol | [Nonalcoholic steatohepatitis: pathogenesis and treatment]. | 2008 | Details |
| A27455 | 18360697 | Int J Mol Med | SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. | 2008 | Details |
| A27456 | 18356751 | Pediatr Res | Nonalcoholic fatty liver disease and carotid atherosclerosis in children. | 2008 | Details |
| A27457 | 18349115 | Am J Physiol Endocrinol Metab | A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. | 2008 | Details |
| A27468 | 18330955 | World J Gastroenterol | Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. | 2008 | Details |
| A27472 | 18324772 | J Agric Food Chem | Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. | 2008 | Details |
| A27475 | 18317656 | Arq Gastroenterol | [Non alcoholic fatty liver disease: treatment with soluble fibres]. | 2008 | Details |
| A27477 | 18317565 | J Clin Invest | Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. | 2008 | Details |
| A27478 | 18315584 | Aliment Pharmacol Ther | Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime. | 2008 | Details |
| A27480 | 18311774 | Hepatology | Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. | 2008 | Details |
| A27482 | 19885351 | J Diabetes Sci Technol | Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes. | 2008 | Details |
| A27487 | 18299664 | Minerva Gastroenterol Dietol | The clinical aspects of non-alcoholic fatty liver disease. | 2008 | Details |
| A27488 | 18297441 | J Gastroenterol | Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients. | 2008 | Details |
| A27491 | 18289064 | Curr Pharm Des | Models for non-alcoholic fatty liver disease: a link with vascular risk. | 2008 | Details |
| A27494 | 18273497 | Rom J Morphol Embryol | Nonalcoholic fatty liver disease and metabolic syndrome: a concise review. | 2008 | Details |
| A27495 | 18270241 | Gut | Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. | 2008 | Details |
| A27497 | 18267346 | J Hepatol | Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. | 2008 | Details |
| A27499 | 18264740 | Obes Surg | Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity. | 2008 | Details |
| A27500 | 18261709 | Dig Liver Dis | A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27502 | 18251167 | Hepatogastroenterology | Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha. | 2008 | Details |
| A27504 | 18249301 | Eur J Intern Med | Evolving trends in nonalcoholic fatty liver disease. | 2008 | Details |
| A27508 | 18240340 | World J Gastroenterol | The blind men 'see' the elephant-the many faces of fatty liver disease. | 2008 | Details |
| A27509 | 18239590 | Obesity (Silver Spring) | ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. | 2007 | Details |
| A27511 | 18220286 | Hepatology | Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. | 2008 | Details |
| A27514 | 18219772 | Obes Surg | Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. | 2007 | Details |
| A27525 | 18186554 | World J Gastroenterol | Nonalcoholic fatty liver disease and mitochondrial dysfunction. | 2008 | Details |
| A27526 | 18186553 | World J Gastroenterol | Non-alcoholic fatty liver disease and the metabolic syndrome: an update. | 2008 | Details |
| A27529 | 18177470 | Clin Genet | Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload. | 2007 | Details |
| A27530 | 18177455 | Am J Gastroenterol | Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. | 2008 | Details |
| A27531 | 18176957 | World J Gastroenterol | Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. | 2008 | Details |
| A27532 | 18176372 | Gastroenterol Clin Biol | [Metabolic fatty liver diseases: hepatic consequences of the metabolic syndrome]. | 2007 | Details |
| A27534 | 18174272 | Am J Physiol Gastrointest Liver Physiol | Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. | 2008 | Details |
| A27540 | 18158823 | J Med Food | Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. | 2007 | Details |
| A27541 | 18098321 | Hepatology | Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. | 2008 | Details |
| A27542 | 18097299 | J Clin Gastroenterol | Nonalcoholic fatty liver disease induced by leuprorelin acetate. | 2008 | Details |
| A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
| A27547 | 18087267 | Int J Obes (Lond) | Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. | 2007 | Details |
| A27548 | 18086620 | Hepatobiliary Pancreat Dis Int | Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. | 2007 | Details |
| A27549 | 18086506 | J Hepatol | Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. | 2007 | Details |
| A27551 | 18081738 | Aliment Pharmacol Ther | Adipokines and cytokines in non-alcoholic fatty liver disease. | 2007 | Details |
| A27554 | 18075282 | J Endocrinol Invest | Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. | 2007 | Details |
| A27557 | 18074733 | Acta Gastroenterol Belg | Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. | 2008 | Details |
| A27559 | 18072723 | Mol Pharm | Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. | 2007 | Details |
| A27561 | 18062158 | Praxis (Bern 1994) | [Non-alcoholic steatohepatitis--a new epidemic]. | 2007 | Details |
| A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
| A27566 | 18054554 | Gastroenterology | Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. | 2007 | Details |
| A27571 | 18035683 | Verh Dtsch Ges Pathol | [Alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
| A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |